Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • WATSON PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 520.78 M 216.35 M 160.82 M 629.93 M 680.33 M
    Net Receivables 305.01 M 267.12 M 384.69 M 333.83 M 251.46 M
    Total Inventories 473.13 M 490.60 M 517.24 M 278.06 M 321.30 M
    Progress Payments & Others -34.71 M 0.00 0.00 0.00 0.00
    Prepaid Expenses 86.07 M — — — —
    Other Current Assets 159.50 M 113.63 M 198.93 M 118.61 M 117.10 M
    Current Assets Total 1.46 B 1.17 B 1.26 B 1.36 B 1.37 B
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 59.69 M 50.30 M 46.88 M 35.48 M 5.10 M
    Other Investments 413,000.00 457,000.00 1.82 M 2.20 M 26.91 M
    Property, Plant & Equipment Net 658.46 M 688.18 M 697.42 M 436.15 M 427.38 M
    Property, Plant & Equipment Gross 1.07 B 1.02 B 1.03 B 717.40 M 647.61 M
    Accumulated Depreciation 411.44 M 327.81 M 329.62 M 281.25 M 220.24 M
    Other Assets 1.45 B 1.50 B 1.70 B 1.22 B 1.38 B
    Deferred Charges — — — — —
    Tangible Other Assets 20.53 M 17.27 M 27.68 M 12.65 M 15.49 M
    Intangible Other Assets 1.43 B 1.48 B 1.67 B 1.21 B 1.37 B
    Total Assets 3.63 B 3.41 B 3.71 B 3.05 B 3.21 B
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 53.22 M 6.24 M 107.06 M 0.00 0.00
    Accrued Payroll 82.00 M 72.71 M 68.69 M 43.46 M 35.68 M
    Income Taxes Payable 31.33 M 18.78 M 46.77 M 28.79 M 57.85 M
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 167.41 M 188.93 M 267.66 M 112.26 M 100.28 M
    Current Liabilities Total 482.00 M 444.93 M 689.93 M 245.67 M 255.63 M
    Long Term Debt 824.68 M 899.41 M 1.12 B 587.94 M 587.65 M
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 0.00
    Deferred Taxes 122.02 M 116.85 M 148.51 M 100.06 M 110.68 M
    Deferred Income 30.09 M 39.54 M 58.09 M 13.89 M 11.56 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 58.25 M 59.95 M 4.17 M 2.50 M 4.74 M
    Total Liabilities 1.52 B 1.56 B 2.02 B 950.06 M 970.25 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 2.11 B 1.85 B 1.68 B 2.10 B 2.24 B
    Common Stock 376,000.00 373,000.00 369,000.00 367,000.00 362,000.00
    Capital Surplus 995.92 M 968.74 M 937.31 M 923.62 M 880.20 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -9.33 M — — — —
    Unappropriated (Free) Reserves 0.00 0.00 0.00 — —
    Retained Earnings 1.42 B 1.18 B 1.04 B 1.49 B 1.35 B
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -3.17 M 2.39 M 1.07 M 4.48 M 9.54 M
    Treasury Stock 302.66 M 301.78 M 300.00 M 300.00 M 0.00
    Total Liabilities & Shareholders Equity 3.63 B 3.41 B 3.71 B 3.05 B 3.21 B
    Common Shares Outstanding 104.61 M 103.66 M 111.87 M 111.20 M 109.72 M